Cardiovascular-kidney-metabolic health and all-cause and cause-specific mortality in the UK Biobank cohort
Lead Institution:
First Affiliated Hospital of Jinan University
Principal investigator:
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
About
There is a high burden of poor cardiovascular-kidney metabolic health in general population, which affects nearly all organ systems and has potent impact on the incidence of cardiovascular disease. More guidance is needed on definitions, staging, prediction strategies, and algorithms for the prevention and treatment of cardiovascular-kidney-metabolic (CKM) syndrome to optimize CKM health across diverse clinical and community settings. Regrettably, there have been limited efforts to translate individual cardiovascular and kidney risk profiles into a visual tool and explore their prognostic roles in long-term outcomes among the general population. In our study, we will use data from UK Biobank cohort to establish a scoring system for CKM consisting of a series of risk factors. Achieving optimal CKM control were associated with lower risk of mortality and longer life expectancy.